CEO Jean Jacques Bienaime sold $3.9M of BioMarin Pharmaceutical Inc.

Sold$3,910,319

$78.21Price

50,000Shares

−8%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, May 6. Filed Mon, May 10, 9:07 PM ET, after the close. Not investment advice.